Product NDC: | 55390-100 |
Proprietary Name: | Buprenorphine Hydrochloride |
Non Proprietary Name: | Buprenorphine Hydrochloride |
Active Ingredient(s): | .324 mg/mL & nbsp; Buprenorphine Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-100 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076931 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050525 |
Package NDC: | 55390-100-10 |
Package Description: | 10 VIAL in 1 BOX (55390-100-10) > 1 mL in 1 VIAL |
NDC Code | 55390-100-10 |
Proprietary Name | Buprenorphine Hydrochloride |
Package Description | 10 VIAL in 1 BOX (55390-100-10) > 1 mL in 1 VIAL |
Product NDC | 55390-100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Buprenorphine Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20050525 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | BUPRENORPHINE HYDROCHLORIDE |
Strength Number | .324 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA] |